The Board of Regents of the University of Texas System
发明人:
Lawrence LUM,Michael G. ROTH,Baozhi CHEN,Chuo CHEN,Michael E. DODGE,Wei TANG
申请号：
US14728105
公开号：
US20150374696A1
申请日:
2015.06.02
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention generally relates to protein signalling. In particular, compounds that inhibit the Wnt protein signalling pathway are disclosed. Such compounds may be used in the treatment of Wnt protein signalling-related diseases and conditions such as cancer, degenerative diseases, type II diabetes and osteopetrosis.
